SEC Form 4 · accession 0001324222-26-000001
ELITE PHARMACEUTICALS INC /NV/ · ELTP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Barry H Dash
Director
Period of report
Aug 19, 2026
Accepted (ET)
Sep 10, 2026 · 1:29 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001053369
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 19, 2026 | P | 30,000 | $0.287 | A | 3,265,555 | D |
Table II — derivative securities
No Table II lines on this filing.